Oculus Innovative Sciences Inc. (NASDAQ:OCLS) shares traded up 9.5% on Wednesday . The stock traded as high as $4.75 and last traded at $4.36, with a volume of 613,487 shares traded. The stock had previously closed at $3.98.

Separately, Maxim Group reaffirmed a “buy” rating and set a $7.00 price objective on shares of Oculus Innovative Sciences in a research report on Thursday, August 11th.

The company’s market cap is $18.86 million. The stock has a 50 day moving average of $4.13 and a 200-day moving average of $4.67.

Oculus Innovative Sciences (NASDAQ:OCLS) last announced its earnings results on Thursday, July 28th. The company reported ($0.61) earnings per share (EPS) for the quarter. Equities research analysts expect that Oculus Innovative Sciences Inc. will post ($2.04) EPS for the current fiscal year.

Oculus Innovative Sciences, Inc is a specialty pharmaceutical company, which focuses on identifying, developing and commercializing therapies to manage the lives of patients with dermatologic diseases or conditions. The Company’s products treat certain topical skin diseases, including acne, atopic dermatitis, scarring, infections, itch, pain and inflammatory responses.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.